David Houston
Family Medicine · Pandora, OHNPI 1386630309
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 401 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 401 payments — averaging $12.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$803
- AbbVie$595
- Lilly USA, LLC$405
- Pfizer$365
- Amgen$344
- Merck$340
- plus $2K from 33 others
What the payments were for
- Food & beverage$5,129100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 64 | $803 |
| AbbVie(2 entities) | 52 | $595 |
| Lilly USA, LLC | 43 | $405 |
| Pfizer | 37 | $365 |
| Amgen | 25 | $344 |
| Merck | 34 | $340 |
| Boehringer Ingelheim | 19 | $333 |
| AstraZeneca | 15 | $265 |
| Amarin Pharma, Inc. | 9 | $151 |
| Biohaven Pharmaceuticals, Inc. | 9 | $151 |
| Astellas Pharma US Inc | 8 | $150 |
| Kowa Pharmaceuticals America, Inc. | 7 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $104 |
| Novartis | 6 | $97 |
| Eisai Inc. | 4 | $80 |
| GSK | 6 | $77 |
| Johnson & Johnson | 4 | $66 |
| Esperion Therapeutics, Inc. | 4 | $62 |
| Mylan Specialty L.p. | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $58 |
| Bayer | 3 | $55 |
| Sanofi-aventis U.S. LLC | 4 | $55 |
| Sunovion Pharmaceuticals Inc. | 4 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Bioventus LLC | 2 | $30 |
| Biogen | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Abbott | 2 | $29 |
| Kaleo, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Adamas Pharmaceuticals, Inc. | 2 | $25 |
| Edwards Lifesciences | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 2 | $22 |
| Dexcom, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Circassia Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
How this compares
$5,142 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Pandora
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.